Get the latest news, insights, and market updates on CLS (Celestica Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Traders Left With ‘Unscratchable Itch’ for Anthropic Exposure
For nearly a month investors have raced to dump shares of companies that could be disrupted by AI tools like Anthropic’s Claude Cowork. Sharp selling has been seen by a wide variety of sectors including software, legal services, wealth management and transportation logistics on worries that the tools could erode growth, demand and pricing power at traditional companies. This absence of publicly traded companies that offer some kind of exposure or correlation to Anthropic is becoming a frustration for traders, who are instead stuck trying to side-step the growing a list of stocks that have plunged because of its tools. Feb 19, 2026 - $CLS
Wall Street Bulls Look Optimistic About Celestica (CLS): Should You Buy?
Based on the average brokerage recommendation (ABR), Celestica (CLS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? Feb 18, 2026 - $CLS
Celestica Lifts 2026 Outlook On AI Data Center Demand And Risks
Celestica (TSX:CLS) has raised its 2026 revenue outlook, citing strong demand tied to AI related data center technologies. The company points to deeper, multi year alignment with customers on AI infrastructure investments as a key driver. The revision marks a material shift in business expectations and comes alongside fresh analyst attention on the stock. For investors watching AI infrastructure, Celestica sits directly in the flow of spending on data center hardware and related services... Feb 18, 2026 - $CLS
The Street is Bullish on Celestica Inc. (CLS), Here’s Why
Celestica Inc. (NYSE:CLS) is one of the Best Performing Foreign Stocks to Buy Now. Wall Street has a positive opinion on Celestica Inc. (NYSE:CLS) since the company topped earnings expectations during fiscal Q4 2025. Recently, on February 5, John Shao from TD Cowen reiterated a Hold rating on the stock with a $330 price target. […] Feb 17, 2026 - $CLS
CLS vs. JBL: Which EMS Stock is a Better Buy Right Now?
AI data center expansion is intensifying competition between Celestica and Jabil, as hyperscaler deals, next-gen switches and rising estimates reshape the EMS landscape. Feb 17, 2026 - $CLS
Barclays Raises Celestica Inc. (CLS) Price Target to $391, Reiterates Overweight
We recently published an article titled 11 Best Canadian Growth Stocks to Buy According to Hedge Funds. On January 30, Barclays raised its price target on Celestica Inc. (NYSE:CLS) to $391 from $359 while reiterating an Overweight rating, following the company’s upward revision to its fiscal 2026 outlook by approximately $1 billion. The analyst characterized […] Feb 17, 2026 - $CLS
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.